Investors

Download Presentation

Investment Highlights

Onco-Innovations is transforming oncology through science, AI, and strategic acquisitions

Mission-Driven Innovation

Committed to revolutionizing oncology care by delivering life-saving treatments through precision medicine and cutting-edge AI technologies.

Mission-Driven Innovation

Committed to revolutionizing oncology care by delivering life-saving treatments through precision medicine and cutting-edge AI technologies.

Mission-Driven Innovation

Committed to revolutionizing oncology care by delivering life-saving treatments through precision medicine and cutting-edge AI technologies.

Mission-Driven Innovation

Committed to revolutionizing oncology care by delivering life-saving treatments through precision medicine and cutting-edge AI technologies.

Novel Drug Development

Proprietary colorectal cancer technologies focused on a $18 billion market opportunity on the horizon. ³

Novel Drug Development

Proprietary colorectal cancer technologies focused on a $18 billion market opportunity on the horizon. ³

Novel Drug Development

Proprietary colorectal cancer technologies focused on a $18 billion market opportunity on the horizon. ³

Novel Drug Development

Proprietary colorectal cancer technologies focused on a $18 billion market opportunity on the horizon. ³

Strategic Acquisition of Inka Health

Integration of Inka’s AI-driven SynoGraph™ platform enhances clinical trial success and accelerates R&D possibilities; strengthens Onco’s competitive edge plus big pharma partners and more.

View Press Release

Strategic Acquisition of Inka Health

Integration of Inka’s AI-driven SynoGraph™ platform enhances clinical trial success and accelerates R&D possibilities; strengthens Onco’s competitive edge plus big pharma partners and more.

View Press Release

Strategic Acquisition of Inka Health

Integration of Inka’s AI-driven SynoGraph™ platform enhances clinical trial success and accelerates R&D possibilities; strengthens Onco’s competitive edge plus big pharma partners and more.

View Press Release

Strategic Acquisition of Inka Health

Integration of Inka’s AI-driven SynoGraph™ platform enhances clinical trial success and accelerates R&D possibilities; strengthens Onco’s competitive edge plus big pharma partners and more.

View Press Release

Market Opportunity & Scalability

Positioned in a $500 billion global oncology market¹, with the precision medicine² market projected to grow from $87.5 billion in 2023 to $249.24 billion by 2030, achieving a total growth of 184.8%.

Market Opportunity & Scalability